Our #NSPLife team is delighted to wear our support for #WorldDuchenneAwarenessDay on September 7! Check out these friendly faces clothed in this year’s Jett Foundation Stronger Than Duchenne t shirts. It’s always the right time to wear red and support patients with #Duchenne muscular dystrophy and their caregivers! #WDAD2024 #raredisease
关于我们
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-licensing them to the world. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies.
- 网站
-
https://www.nspharma.com
NS Pharma, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Paramus,New Jersey
- 类型
- 私人持股
- 创立
- 1999
- 领域
- Hematology、Orphan Diseases、Urology、Gynecology和ENT
地点
-
主要
140 E Ridgewood Ave
US,New Jersey,Paramus,07652
NS Pharma, Inc.员工
动态
-
ようこそ (Welcome), Hiroji Hayashi ?? Hiroji has joined our team as advisor to the Office of the President. While Hiroji isn’t entirely new to NS Pharma, having previously worked for our parent company in Japan, we’re delighted to have him join us in the U.S.! Hiroji began his career in human resources and has since progressed through various roles, including business administration, corporate planning, account management and personnel affairs. He has consistently demonstrated strong leadership and dedication, and his expertise will be invaluable as he supports our President in overseeing management activities. Please join us in welcoming Hiroji and celebrating this exciting new chapter! #NewHire #NewRole #NSPLife
-
Mark your calendars! CureDuchenne is hosting another amazing session tomorrow. ?? If you're in Detroit, be sure to sign up for what promises to be another inspiring afternoon with an incredible group of caregivers, families, and healthcare professionals who are dedicated to improving the lives of people with Duchenne muscular dystrophy. #DuchenneCommunity #CureDuchenneCares #RareDisease
-
Continuing our "Meet the NS Pharma Team" series, we’re excited to introduce Clinical Research Manager, Victoria Ramirez, MPA, who works to advance medical research and understands first-hand the impact that clinical trials and new treatments can have on the lives of patients. Victoria is a stage 2 triple negative #breastcancer survivor who can personally attest to the importance of early detection. She volunteers with the American Cancer Society and helps raise money for its Making Strides Against Breast Cancer movement. To make a donation to Making Strides, visit: https://lnkd.in/ec_P8W_n #NSPLife #patientadvocacy #team
-
We’re excited to sponsor and exhibit at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Savannah, Georgia! This event is dedicated to supporting research and collaboration to benefit the #Duchenne muscular dystrophy community. Please visit our team at Booth 423 during the meeting, October 15 to 18, at the Savannah Convention Center and Westin Savannah Harbor. #AANEMAnnualMeeting #AANEMinSavannah #raredisease
-
Our team had a fantastic time in Prague last week for #WMS2024! A huge thanks to everyone who stopped by our booth. It was a pleasure to meet you and explore treatment innovations for #Duchenne muscular dystrophy and other #NeuroMuscularDisorders. Pictured are Donald Foy, Stephen Sudovar and Jonathan Cabral, leaders of our Commercial team, and Project Manager, Business Strategy of our parent company, Nippon Shinyaku. #NSPLife #TeamWork
-
We’re thrilled to share that the results from our Galactic53 trial studying patients with #DuchenneMuscularDystrophy have been published in Scientific Reports! This study evaluated the effects of treatment on pulmonary function and has shown promising results for both ambulatory and non-ambulatory participants - a significant achievement in our on-going efforts to improve the lives of those affected by #Duchenne. Check out the press release to find out more: https://lnkd.in/e4ziTxSA #raredisease #ClinicalTrials #DMD
-
A warm welcome to our new Medical Science Liaison for the North Central region, Terese Geraghty, PhD! Terese earned her B.S. in biochemistry and molecular biology from Michigan State University and received her Ph.D. in immunology and microbiology from Rush University Medical Center in Chicago. Her dissertation focused on the efficacy and mechanisms of a small molecule agonist of integrin CD11b as a novel cancer immunotherapy, and her postdoctoral work focused on studying the neuro-immunology of chronic pain in osteoarthritis. With such broad scientific expertise and a strong research background, we're delighted to have her onboard as our newest MSL! #NewHire #Careers #NSPLife
-
We’re excited to catch up with our team members who attended a Jett Foundation Family Workshop in Portland, Maine in September to help empower patients and families with the knowledge they need to be their own best advocates! Pictured are Patient Engagement Liaison, TONI SPEAR and Medical Science Liaison, Mary Fayazi. Thank you to all of the patients, families and advocates who came out to support the #Duchenne community. #NSPLife #RareDisease #PatientAdvocacy
-
The NSP team have just arrived in the beautiful Prague for #WMS2024 and we're excited to join the global neuromuscular community for a week of networking! We're delighted to be Bronze Sponsors of this prestigious event. It's a fantastic opportunity to liaise with the leading experts in the field of neuromuscular disorders and we're eager to share our commitment to advancing treatment options for Duchenne muscular dystrophy! #NeuromuscularDisorders #DMD